Related Experiment Videos
Tumor-infiltrating lymphocytes: their phenotype, functions and clinical use
1Pittsburgh Cancer Institute Immunologic Monitoring and Diagnostic Laboratory, University of Pittsburgh School of Medicine, Pa. 15213-2582.
Cancer Immunology, Immunotherapy : CII
|July 1, 1994
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Three-year follow-up of advanced melanoma patients who received ipilimumab plus fotemustine in the Italian Network for Tumor Biotherapy (NIBIT)-M1 phase II study.
Annals of oncology : official journal of the European Society for Medical Oncology·2014
Clonal analysis of the cytolytic T-cell response to human tumors.
Immunology today·2014
Allostimulation-induced tumor cytotoxic cells: from mouse to man.
Immunology today·2014
Efficacy and safety of ipilimumab in patients with pre-treated, uveal melanoma.
Annals of oncology : official journal of the European Society for Medical Oncology·2013
Gene therapy in melanoma.
Methods in molecular medicine·2012
Multipeptide vaccination in cancer patients.
Expert opinion on biological therapy·2009
The CREM-IL-15 axis: decoding the persistence-exhaustion paradox in NK cell immunotherapy.
Cancer immunology, immunotherapy : CII·2026
Therapeutic targeting of CD47 using a tri-specific NK cell engager to inhibit multiple myeloma.
Cancer immunology, immunotherapy : CII·2026
Mast cells in tumors: dual roles and therapeutic potential.
Cancer immunology, immunotherapy : CII·2026
Preclinical efficacy of iPSC-derived MUC1-targeted CAR-NK cells against esophageal squamous cell carcinoma.
Cancer immunology, immunotherapy : CII·2026
HBO1 suppresses anti-tumor immunity of CD8⁺ T Cells in thyroid cancer by recruiting BRD4 to regulate VTCN1 expression.
Cancer immunology, immunotherapy : CII·2026
Extravascular distribution of factor IX-review of experimental and clinical evidence, and relevance for hemophilia B replacement therapy.
Research and practice in thrombosis and haemostasis·2026
Simultaneous targeting of IL-10 and PD-(L)1 pathways with a bispecific anti-PD-L1/IL-10-trap antibody enhances T cell responses.
Molecular therapy. Oncology·2026
SARS-CoV-2-induced IgG repertoires shape T cell responses, microRNA regulation, and autoreactivity according to disease severity.
Journal of translational autoimmunity·2026